Navigation Links
Telomere Biosciences Announces: TELO-100 with T-Activator 150, a Breakthrough in Telomere Science and Age Management
Date:11/21/2013

COLD SPRING, N.Y., Nov. 21, 2013 /PRNewswire/ -- Telomere Biosciences, LLC. (Telomere Biosciences) announced today the launch of their Nutraceutical "TELO-100 with T-Activator 150"™, the first and only supplement in the world to target all major causes of Telomere shortening, to help promote and extend human healthspan. Telomeres are the protective caps at the ends of every chromosome in the body. A wealth of ground-breaking research by some of the world's leading experts in Telomere Science and Aging, including Nobel laureates, has demonstrated a strong connection between short Telomeres and many of the negative conditions associated with human aging.  

"Telomere Biosciences is excited and proud to launch TELO-100 with T-Activator 150," said David B. Cross, founder of Telomere Biosciences. "And while TELO-100 includes 9 natural compounds documented to activate the Telomere-lengthening enzyme, telomerase, TELO-100 is much more than just a telomerase activator, however, as the latest research in Telomere Science through 2013 shows conclusively that there are several key factors which lead to Telomere shortening, all of which should be addressed to have the greatest positive impact on Telomere length."

At a recent conference of leading Age Management Medicine Physicians, Dr. Keith Fleischman gave the following summary: "Oxidative stress, inflammation, and increased cell renewal accelerate the ongoing shortening of chromosomal telomeres...Through attention to reducing accelerants of telomere shortening and through the use of supporters and activators of telomerase activity we may be able to exert influence" over many physiologic processes related to aging.

With its integrated "complex" of 17 pro-Telomere ingredients, TELO-100 is the first and only Nutraceutical to target not only telomerase activation ('TA'), but also the other major causes of Telomere shortening--including oxidative stress, inflammation, homocysteine, and the 'stress-hormone' cortisol--in one comprehensive Telomere product.

"The Mission of Telomere Biosciences is clear," added Cross: "To bring the breakthrough health benefits of Nobel prize-winning Telomere Science to a mass audience globally, applying the very latest research in the field to products like TELO-100, the most advanced Telomere Nutraceutical available. And we are equally committed to making this leading-edge science and product price-accessible not only to the wealthy, but to all those who can benefit from longer Telomeres for a longer healthspan." TELO-100 is available both through Healthcare Practitioners and directly to consumers.

About Telomere Biosciences:
Telomere Biosciences, founded in 2010, is located at 10 North St., Cold Spring, NY, and is privately held. 
For more information on Telomere Biosciences and TELO-100 visit www.TelomereBiosciences.com 
Media Contact: Telomere Biosciences, Info@TelomereBiosciences.com


'/>"/>
SOURCE Telomere Biosciences, LLC.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Telomere Diagnostics, Inc. (TDx), previously known as Telome Health, Inc., announces its name change
2. Stem Cell and Telomere Support Provided by Stem Cell 100 from Life Code
3. Life Length Telomere Test Available Nationwide
4. Sangamo BioSciences Announces Seven Data Presentations At The 2013 American Society of Hematology Annual Meeting
5. Proove Biosciences Will Be Exhibiting at the National Workers Compensation Conference and Expo on November 20-22
6. Proove Biosciences to Present Research on the Genetics of Pain Medicine and Exhibit at ASRA’s 12th Annual Pain Medicine Meeting
7. Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimers Disease Program
8. Ambit Biosciences Announces Third Quarter 2013 Operating Results
9. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
10. Juneau Biosciences Names Dr. Dinesh Patel to Board of Directors
11. Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) ... December 31, 2015. --> --> ... net loss of $29.3 million, or $0.34 loss per share, compared ... share for the same period in 2014. For the year ended ... million, or $1.05 loss per share, as compared to a net ...
(Date:2/11/2016)... ATLANTA , Feb. 11, 2016  Spectra BioPharma ... Organization (CSO) that provides biopharma companies the experience, ... implement and deploy outsourced sales teams. Created in ... team addresses both the strategic and tactical needs ... innovative sales solutions through both personal and non-personal ...
(Date:2/11/2016)... 2016 --> ... (OTCQB: PSID), a life sciences company focused on ... subsidiary, which markets the Caregiver® FDA-cleared non-contact thermometer, ... January 2016, including entering into agreements with five ... growth, and establishing several near-term pipeline opportunities. ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... of its new stem cell treatment clinic in Quito, Ecuador. The new facility ... and trauma applications to patients from around the world. , The new ...
Breaking Biology Technology:
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/3/2016)... 3, 2016 --> ... report "Automated Fingerprint Identification System Market by Component (Hardware ... (Banking & Finance, Government, Healthcare, and Transportation) and Geography ... market is expected to be worth USD 8.49 Billion ... 2015 and 2020. The transformation and technology evolution from ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
Breaking Biology News(10 mins):